Atlantic Union Bankshares Corp Has $389,000 Position in Abrdn Life Sciences Investors (NYSE:HQL)

Atlantic Union Bankshares Corp trimmed its position in Abrdn Life Sciences Investors (NYSE:HQL) by 4.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,803 shares of the company’s stock after selling 1,300 shares during the quarter. Atlantic Union Bankshares Corp owned 0.09% of Abrdn Life Sciences Investors worth $389,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in HQL. Future Financial Wealth Managment LLC acquired a new position in shares of Abrdn Life Sciences Investors in the third quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new position in shares of Abrdn Life Sciences Investors during the 3rd quarter worth approximately $148,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Abrdn Life Sciences Investors during the first quarter worth approximately $143,000. Kapstone Financial Advisors LLC acquired a new stake in shares of Abrdn Life Sciences Investors in the third quarter valued at approximately $177,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of Abrdn Life Sciences Investors in the second quarter valued at approximately $154,000. Institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Price Performance

Shares of NYSE:HQL opened at $14.26 on Friday. The business’s 50 day simple moving average is $14.76 and its 200 day simple moving average is $14.68. Abrdn Life Sciences Investors has a 1 year low of $11.78 and a 1 year high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Thursday, November 21st will be issued a dividend of $0.50 per share. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49. This represents a $2.00 annualized dividend and a dividend yield of 14.03%. The ex-dividend date of this dividend is Thursday, November 21st.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.